Form 4: Heartflow CMO Sells Shares for Tax Obligations

Heartflow's Chief Medical Officer, Campbell Rogers, disposed of 439 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Campbell Rogers, Chief Medical Officer of Heartflow, Inc. (HTFL), reported a transaction on November 7, 2025.
• The transaction involved the disposition of 439 shares of Heartflow Common Stock.
• The shares were disposed of at a price of $32.56 per share.
• This disposition was made to the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
• Following this transaction, Campbell Rogers directly beneficially owns 20,613 shares of Common Stock.
• Indirect beneficial ownership includes 22,615 shares via the Campbell Rogers 2019 Irrevocable Trust, 46,159 shares via the CR Asset Protection Trust of 2023, 26,012 shares via Spouse's Trust, and 50,754 shares via The Campbell Rogers Revocable Trust.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary disposition of shares for tax withholding purposes, which is a routine event and does not indicate a positive or negative sentiment towards the company's prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries and does not reflect specific industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in the executive's investment thesis or company fundamentals.

Key Dates

Keywords

Heartflow, HTFL, Form 4, insider transaction, Campbell Rogers, Chief Medical Officer, tax withholding, restricted stock units, equity compensation